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SUMMARY 
Two potential lipophilic myelin imaging agents ( 1  ,l, 2,2-tetrafluoro-1,2-di- 
phenylethane and 1-fluoroadamantane) were tritium labeled. The most effective 
method employed the microwave discharge activation of tritium gas technique and 
resulted in specific activities of 177 mCi/mmol for 1,1,2,2-tetrafluoro-l,Z-di- 
phenylethane and 593 mCi/mmol for 1-fluoroadamantane. Using this tritiation 
method significant amounts of tritium-for-fluorine substitution was also observed 
in the labeling of I-fluoroadamatane, resulting in nearly equivalent amounts of 
tritiated adamantane and fluoroadamantane. 
Key Words: Tritium labeling, Exchange labeling, Microwave discharge labeline, 
Myelin. Positron Fmission Tomography 
INTKODUCT JON 
Altnough a number of neurological disorders are primarily or entirely nani- 
fectcd in white matter of the brain, there currently exists no clinical diagnostic 
procedure for the noninvasive quantitative evaluation of brain myel in structure 
and composition. Several clinical imaging methods under development at present 
offer the potential to differentially image myelin in the human brain. Tomographic 
nuclear magnetic resonance (NMR) scanning has been used to demonstrate brain 
white matter in both normal (1) and patbologic conditions (1,2). A second approach 
to tomographic myelin imaging involves the use of lipophilic gamma (3) or positron 
( 4 , 5 )  emitting radiotracers which preferentially accumulate in white matter 
under equilibrium conditions. The current study is aimed at the tritium labeling 
of several potential lipophilic myelin probes to he used for in vivo animal evalua- 
tion. 
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The compounds, 1.1,2,2-tetrafluoro-l,Z-diphenylethane (tetrafluorobibenzyl, TFBB) 
and 1-fluoroadamantane (FAd), were chosen for three reasons, 1) their expected ease 
of labeling (6:7,8) with the short lived positron emitting isotope 18F (T 1/2 110 min) 
using I8F-F2 (9) lend them well to positron emission tomographic (PET) studies, 2) the 
18F labeled compounds are likely to be biologically stable (10) and 3)  both TFBB and 
FAd are highly lipophilic and thus would be expected to concentrate in brain myelin. 
MATERIALS AND METHODS 
Adamantane and 1-bromoadamantane were purchased from Aldrich Chemicals trans 1,2- 
difluorostilbene from PCR and Freon-11 and 2% FZ/Neon from Matheson. These were used 
as received from the suppliers. Silica Gel (TLC and hulk) were purchased from Merck. 
The catalytic exchange tritiations were carrjed out by New England Nuclear 
Tritium Labeling Service Division. The microwave discharge activation labelings were 
carried out at Brookhaven Natlonal Laboratory in the Department of Chemistry. These 
tritiations used Metricel TCM-200 filters as the substrate support surface purchased 
from Gelman and tritium gas (3H2) supplied by Oak Ridge National Laboratory. 
HPLC analyses were carried out on a Waters Model 6000A chromatograph equipped 
with a U6K injector and 440 UV absorbance monitor monitored at 254 nm. Columns used 
were: VBondapak C-18 (Waters) and MicroPak Si-10, CN-10 and MCH-10 (Varian). GLC 
analyses were carried out on a Varian 4600 GLC with the CDS-401 Data System. 
Tritiated snmples were counted using both a Reckman LS-I1 and a Packard 460 CD 
liquid scintillation spectrometers with internal standard calibration. 
Tetrafluorobibenzyl was prepared by direct fluorination with elemental fluorine 
(F2) of 1,2-difluorostilbene (-78" in Freon-11) by the method of Guzikowski, 
MacGregor and Fowler (6) purified by silica gel chromatography and recrystallization 
from ethanol. Fluoroadamantane was prepared both by direct fluorination of adamantane 
using the method of Alker, et a1 (7) and by direct fluorination with F2 of l-bromo- 
adamantane as described by Rozen and Brand (8). The latter method was preferred due 
to its higher yield. The fluoroadamantane was also purified by silica gel chroma- 
tography and recrystallization from ethanol. GLC purity determination (OV-101 column 
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a t  100°C) showed t h e  FAd t o  b e  99.5% pure con ta in ing  0.5% r e s i d u a l  1-bromoadamantane. 
T r i t i um Label ing of Te t r a f luo rob ibenzy l  
Method 1. Exchange l a b e l i n g  was at tempted by New England Nuclear T r i t i um 
Label ing Se rv ices .  TFBB (27.0 mg) was d i s so lved  in 0.4 mL of 3 : l  dimethylformamide: 
t r i e t h y l a m i n c  (ve ry  d r y ) ;  t o  t h i s  w a s  added 75 mg of 5% Rh/C c a t a l y s t  and 25 Curies  
of t r i t i a t e d  water .  The r e a c t i o n  mix tu re  was s t i r r e d  f o r  18 hours a t  80°C. Lab i l e  
t r i t i u m  w a s  removed i n  vacuo, u s ing  e thano l  a s  s o l v e n t .  Af t e r  f i l t r a t i o n  from t h e  
c a t a l y s t ,  t h e  product was aga in  taken t o  d ryness ,  in vacuo, and then taken up i n  50 
mL of e thano l .  An a l i q u o t  (50 m C i )  was removed and shipped from 116.27 m C i  produced. 
Th i s  method produced no l abe led  TFBB a s  determined by TLC chromatography ( s i l i c a  
g e l ,  using 10% e the r /90% petroleum e t h e r ) .  A l l  a c t i v i t y  on t h e  TLC p l a t e  remained 
a t  o r  nea r  t h e  o r i g i n .  
Method 2. Carr ied out  a t  New England Nuclear T r i t i um Label ing S e r v i c e s .  TFBB 
(27 mg) was d i s so lved  i n  0 . 3  mL of t r i f l u o r o a c e t i c  a c i d  (ve ry  d r y ) ;  t o  t h i s  w a s  
added 75 mg of 5% Rh/C c a t a l y s t  and 25 Cur i e s  of t r i t i a t e d  wa te r .  The r e a c t i o n  
mix tu re  was s t i r r e d  f o r  16 hours a t  80°C i n  a s ea l ed  system. L a b i l e  t r i t i u m  was 
removed, i n  vacuo, u s i n g  e thano l  a s  s o l v e n t .  A f t e r  f i l t r a t i o n  from the  c a t a l y s t ,  t he  
product w a s  taken t o  d ryness  i n  vacuo, and then  taken up in 50 mL of e thano l .  TLC 
( a s  above) of t h i s  sample showed two peaks,  TFBB (Rf = 0.41)  which contained 62% of 
a c t i v i t y  and a 38% impur i ty  (Rf 0.08).  TFBB prepared by t h i s  method had a c a l c u l a t e d  
s p e c i f i c  a c t i v i t y  of 0.28 mCi/mg (72 mCi/mmol) a f t e r  p u r i f i c a t i o n  by p r e p a r a t i v e  TLC 
on s i l i c a  g e l  u s ing  5% e the r /95% petroleum e t h e r .  Analysis  of t h e  p u r i f i e d  m a t e r i a l  
on s i l ica  g e l  and alumina TLC showed t h e  TFBB t o  be > 98% p u r i t y .  No o t h e r  peaks 
were observed. 
Method 3 .  Microwave Discharge A c t i v a t i o n  of T r i t i um Gas (MDA). Th i s  method 
invo lves  t h e  s o l i d  phase exchange l a b e l i n g  of t h e  s u b s t r a t e  by r e a c t i v e  t r i t i u m  
s p e c i e s  formed by pass ing  a s t ream of t r i t i u m  gas  through a microwave d i scha rpe  
(2450 MHz). This  method h a s  been s u c c e s s f u l l y  used t o  l a b e l  a v a r i e t y  of compounds 
and h a s  been p rev ious ly  desc r ibed  (11 ) .  The l a b e l i n g  of TFBB was c a r r i e d  out using 
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a microporous membrane f i l t e r  a s  t h e  c a r r i e r  s u r f a c e  f o r  t h e  s u b s t r a t e  and a modi f ied  
r e a c t i o n  v e s s e l  capab le  of  ho ld ing  m u l t i p l e  microporous  membrane f i l t e r s  as d e t a i l e d  
i n  r e f e r e n c e  12. Accordingly  3 membrane f i l t e r s  (Gelman Metricel TCM-200 47 mm i n  
d i ame te r  0.20 v m  po re  s i z e )  were coa ted  w i t h  a s o l u t i o n  of TFBB (2 .06  mg/200 pL 
hexane) and a l lowed t o  a i r  d ry .  The t h r e e  f i l t e r s ,  h e l d  i n  a s l o t t e d  t e f l o n  h o l d e r ,  
were placed i n t o  t h e  l a b e l i n g  v e s s e l  and t h e  sys tem w a s  evacua ted .  The l a b e l i n g  
w a s  c a r r i e d  o u t  f o r  6 minutes  u s i n g  4 T o r r  ( 2  C i )  ?-12 g a s  p r e s s u r e .  The t r i t i u m  
g a s  was a c t i v a t e d  u s i n g  30 w a t t s  (2450 MHz) of forward microwave power. The g a s  was 
c i r c u l a t e d  i n  t h e  c l o s e d  l o o p  r e a c t i o n  sys tem w i t h  an  i n t e r n a l  c y c l i n g  pump. The 
s u b s t r a t e  was no t  cooled du r ing  t h e  r e a c t i o n .  During t h e  6 minutes  t h e  p r e s s u r e  
dropped from 4 . 0  t o  1 . 3  t o r r ,  which r e s u l t e d  i n  a n  i n c r e a s e  i n  the s i z e  of t h e  d i s -  
charge  plasma. 
The c rude  TFRB, which was e l u t e d  from t h e  f i l t e r s  u s i n g  10 mL of 95% e thano l  con- 
t a i n e d  168.0 m C i .  The e t h a n o l  w a s  evapora t ed  l e a v i n g  31.7 m C i  of n o n l a b i l e  t r i t i u m .  
Chromatographic p u r i f i c a t i o n  w a s  c a r r i e d  o u t  u s i n g  s u c c e s s i v e  s i l i c a  ge l  columns (10 
cm x C.9 crn) w i t h  hexane as  t h e  e l u t i n g  s o l v e n t .  The f i n a l  p u r i f i c a t i o n  r e s u l t e d  i n  
a recovery  o f  4 .3  m C i  of 3H-TFBB w i t h  a c a l c u l a t e d  s p e c i f i c  a c t i v i t y  (based  on 
6 .18  mg l a b e l e d )  0.70 mCi/mg (177 mCi/mmol). Radiochemical p u r i t y  of t h e  3H-TFBB 
was de te rmined  by TLC (98%)  and by HPLC (95 .6%) .  HPLC a n a l y s i s  w a s  c a r r i e d  out  us ing  
a r e v e r s e  phase C-18 column e l u t e d  w i t h  70% a c e t o n i t r i l e / 3 0 %  water ( i s o c r a t i c )  a t  a 
f low of 1 mL/min. Samples were c o l l e c t e d  and coun ted .  Under t h e s e  c o n d i t i o n s  95.9% 
of t h e  recovered  a c t i v i t y  e l u t e d  wi th  TFBB (11 .5  min) two o t h e r  minor peaks were 
observed accoun t ing  f o r  3.9% ( r e t e n t i o n  t i m e ,  1 2 . 5  mi,) and 0 .2% ( r e t e n t i o n  t i m e ,  16 
min) of t h e  r ecove red  t r i t i u m  a c t i v i t y  r e s p e c t i v e l y .  
T r i t i u m  Labe l ing  of I-Fluoroadamantane 
Method 1. Microwave d i s c h a r g e  a c t i v a t i o n  of t r i t i u m  g a s .  A s  desc r ibed  pre- 
v i o u s l y  f o r  TFBB, t h e  FAd ( 4 . 0  mg i n  200 uL hexane)  w a s  d e p o s i t e d  a Metricel TCM-200 
f i l t e r  (47  mm d i a m e t e r ,  0 .20  u m  pore  s i z e ) .  The s i n g l e  f i l t e r  was exposed t o  t h e  
microwave-activated t r i t i u m  g a s  stream. T r i t i u m  g a s  a t  3.5 t o r r  (1 .75  C i )  w a s  used 
wi th  a microwave power of 30 w a t t s  f o r  1 5  minutes  a t  ambient t empera tu re .  During 
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this time the pressure dropped from 3.5 to 3.0 torr. 80.0 mCi of crude %-FAd was 
recovered from the filter by ethanol elution. Solvent evaporation resulted in 
recovery of 64 mCi of nonlabile tritium. Chromatography on silica gel (10 cm x 0.9 
cm column) using hexane and 10% chloroform/90% hexane resulted in two major tritium 
peaks containing 14.8 mCi and 15.4 mCi. TLC on silica gel (hexane as developing 
solvent) showed the two peaks to be adamantane (Rf=O. 75) and 1-fluoroadamantane (Rf 
0.40) respectively, in a ratio of 0.96/1. This assjgnment was also confirmed by 
comparison with silica gel column chromatography of nonlabeled materials and HPLC 
(see below). The calculated specific activity of the 3H-FAd was 3.85 mCl/mg (593 
mCi/mmol). TLC and HPLC purity analyses are described below. 
Method 2. Direct fluorination of %-adamantam (7). %-Adamantam which was 
recovered from the MDA tritiation of FAd by &I-for-F substitution was used in this 
procedure as the source of %-Ad. To 5.95 mCi of %-Ad was added 20.5 mg (150 umol) 
of "cold" adamantane in 10 mL of Freon-11. The solution was cooled to -78" and 
fluorine gas (2.0% in N2, 0.8 vmol/mL) was bubbled through the solution at 30 mL/min 
for 7 min (168 vmol F2). The reactlon solution was evaporated to dryness with a 
stream of argon gas and the resulting residue (5.34 mCi) chromatographed on silica 
gel (10 cm x 0.9 cm) with hexane, 10% CHC13/90% hexane. Unreacted adamantane ( 4 . 9  
mCi) and fluoroadamantano (375 uCi) were thus separated and collected. The two 
fractions were analyzed by TLC and HFLC for radiochemical purity. 
TLC analysis on silica gel using hexane showed 3H-adamantane to be 99% pure 
(Rf=0.75) with 1% remaining at the origin. 3H-Fluoroadamantane (Rf=0.40) was > 
98% pure with no other observed peaks. 
HPLC analysis of h-adamantane was carried out on a bonded nitrile column using 
100% acetonitrile. Purity was > 98% with no other peaks observed and 103% %I recovery 
from the column. %-fluoroadamantane was chromatographed on a Varian Si-10 silica 
gel column in 100% hexane. Purity was > 98% with no other peaks observed. Tritium 
recovery from the column was 112%. 
Although not used jn these analyses, adamantane and fluoroadamantane despite 
their high melting points are quite volatile and readily chromatographed by GLC 
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a t  ].ow temperatures. Using a 5% OV-101 (50 cm x 1/8”) column a t  100°C and 20 cc/min 
helium flow r a t e ,  fluoroadamantane has a r e t e n t i o n  time of 2 . 3  min, adamantane 
1 . 7  min- 
Octanol/Saline P a r t i t i o n  Coeff ic ien ts  (13) 
Each of the above t r a c e r s  (TFBB, Ad, FAd) was p a r t i t i o n e d  between octanol  and 
aqueous s a l i n e  as an index of t h e i r  l i p o p h i l i c i t y .  The t r i t i a t e d  compound was added 
t o  tubes containing 2 mL each of octanol  and phosphate buffered s a l i n e  (pH 7 . 4 ) ,  
vortexed and f i n a l l y  centr i fuged t o  separa te  t h e  phases. Duplicate a l i q u o t s  were 
analyzed f o r  r a d i o a c t i v i t y  by l i q u i d  s c i n t i l l a t i o n  counting. To de tec t  the possible  
presence of contaminating impur i t ies  i n  t h e  t r i t i a t e d  t r a c e r s  t h e  octanol  phases 
were repar t i t ioned  a g a i n s t  f r e s h  s a l i n e  and t h e  determinat ion of r a d i o a c t i v i t y  i n  
each phase repeated.  
Figure 
Proposed Fluorinated Myelin Agents 
F 
1,1.2,2-tetrafluoro- 
1.2-diphenylethane (TFBB) 1-Fluoroadamantane ( FAd) 
RESULTS AND DISCUSSION 
Labeling of TFBB using Rh/C with a t e r t i a r y  amine ( t r ie thylamine)  and t r i t i a t e d  
water was unsuccessful with t h i s  aromatic system whereas when the  same c a t a l y s t  
was used under acid condi t ions ( t r i f l u o r o a c e t i c  a c i d )  moderate labe l ing  occurred 
( 7 2  mCi/mmol) . In  c o n t r a s t ,  l a b e l i n g  using the microwave a c t i v a t i o n  of t r i t i u m  gas 
method (MDA) with t h e  s u b s t r a t e  deposited on a microporous membrane f i l t e r  yielded a 
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product  t h a t  w a s  r e a d i l y  p u r i f i e d  a t  a s p e c i f i c  a c t i v i t y  of  177 mCi/mmol, a f u r t h e r  
i n d i c a t i o n  of t h e  v e r s a t i l i t y  of t h i s  method. 
T r i t i u m  l a b e l i n g  of fluoroadamantane u s i n g  t h e  MDA method w a s  q u i t e  s t r i k i n g ,  
and r e s u l t e d  i n  a s p e c i f i c  a c t i v i t y  of  n e a r l y  0.6 C i / m m o l  i n  t h e  l a b e l e d  p a r e n t  
compound. Th i s  h igh  s p e c i f i c  a c t i v i t y  may be a t t r i b u t a b l e  t o  l a b e l i n g  a t  t h e  
t e r t i a r y  methyne hydrogens abundant i n  adamantane. S e l e c t i v i t y  f o r  l a b e l i n g  a t  such 
t e r t i a r y  p o s i t i o n s  u s i n g  t h e  MDA method has  a l so  been observed i n  amino a c i d s  (14) 
and i n  c y c l i c  and branched a l k a n e s  (15) .  
In t h e  case of 1-fluoroadamantane l a b e l i n g ,  a second major r e a c t i o n  w a s  observed,  
i . e .  t r i t ium-for-halogen s u b s t l  t u t i o n  producing approximately equa l  amounts of %-I- 
adamantane and %-fluoroadamantane. Th i s  s u p p o r t s  o t h e r  o b s e r v a t i o n s  demonstrat ing 
f ac i l e  t r i t i u m  halogen s u b s t i t u t i o n  when l a b e l i n g  u s i n g  MDA method (16,17) .  Th i s  
by-product c a n  be e i t h e r  a con tamina t ion  nu i sance  o r  d e s i r a b l e  product  y i e l d i n g  a 
s p e c i f i c a l l y  l a b e l e d  carrier f r e e  dehalogenated t racer ,  depending on experimental  
des ign .  With t h i s  in mind, we s u c c e s s f u l l y  r e f l u o r i n a t e d  t h e  3H-adamantane formed 
i n  t h i s  f a s h i o n .  The y i e l d  of t h e  3H-FAd t h u s  produced (6%) d i d  no t  r e p r e s e n t  a n  
opt imized r e a c t i o n ,  and t h e  un reac ted  3H-adamantane was e a s i l y  recovered du r ing  t h e  
chromatographic p u r i f i c a t i o n .  
S i n c e  t h e  purpose of t h i s  s t u d y  was t o  p repa re  l a b e l e d  l i p o p h i l i c  myel in  probes,  
a q u a n t i t a t i v e  de t e rmina t ion  of t h e  l i p o p h i l i c i t y  of t h e s e  t h r e e  compounds was 
c a r r i d  ou t  ( s e e  t a b l e  below). 
TARLE 
Octanol-Sal ine P a r t i t i o n  C o e f f i e i e n t s  
number of 
Tracer 
~H-TFBB 5 .0  + 0.1 
5 . 2  0.1 
3H -F Ad 5.7 5 0.1  
*Log10 of t h e  oc t ano l  t o  phosphate  bu f fe red -  
s a l i n e  (pH 7.4) p a r t i t i o n  c o e f f i c i e n t  ( 1 3 ) .  
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It i s  a n t i c i p a t e d  t h a t  t h e s e  compounds or s t r u c t u r a l l y  related ones i . e . ,  f l u o r i -  
nated a r y l  o l e f i n s  or p r e c u r s o r s  w i t h  m u l t i p l e  t e r t i a r y  C-H bands w i l l  prove su i t ab l r l  
a s  p o s i t r o n  e m i t t i n g  myel in  p robes .  
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